Acute heart failure: How to evaluate left ventricular filling pressure in practice?

Dickstein, 2008, Eur Heart J, 29, 2388, 10.1093/eurheartj/ehn309 Vanderheyden, 2004, Brain and other natriuretic peptides: molecular aspects, Eur J Heart Fail, 6, 261, 10.1016/j.ejheart.2004.01.004 Liang, 2007, Evidence for functional heterogeneity of circulating B-type natriuretic peptide, J Am Coll Cardiol, 49, 1071, 10.1016/j.jacc.2006.10.063 Martinez-Rumayor, 2008, Biology of the natriuretic peptides, Am J Cardiol, 101, 3, 10.1016/j.amjcard.2007.11.012 Maisel, 2002, Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure, N Engl J Med, 347, 161, 10.1056/NEJMoa020233 Steg, 2005, B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnoea, Chest, 128, 21, 10.1378/chest.128.1.21 Logeart, 2002, Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea, J Am Coll Cardiol, 40, 1794, 10.1016/S0735-1097(02)02482-8 Mueller, 2004, Use of B-type natriuretic peptide for the management of women with dyspnea, Am J Cardiol, 94, 1510, 10.1016/j.amjcard.2004.08.029 Januzzi, 2005, The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study, Am J Cardiol, 95, 948, 10.1016/j.amjcard.2004.12.032 Bayes-Genis, 2007, Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea, Arch Intern Med, 167, 400, 10.1001/archinte.167.4.400 Lainchbury, 2003, Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath, J Am Coll Cardiol, 42, 728, 10.1016/S0735-1097(03)00787-3 Anwaruddin, 2006, Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study, J Am Coll Cardiol, 47, 91, 10.1016/j.jacc.2005.08.051 Cowie, 2003, Clinical applications of B-type natriuretic peptide (BNP) testing, Eur Heart J, 24, 1710, 10.1016/S0195-668X(03)00476-7 Cavallazzi, 2008, Natriuretic peptides in acute pulmonary embolism: a systematic review, Intensive Care Med, 34, 2147, 10.1007/s00134-008-1214-5 Torbicki, 2008, Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC), Eur Heart J, 29, 2276, 10.1093/eurheartj/ehn310 Becattini, 2007, Prognostic value of troponins in acute pulmonary embolism: a meta-analysis, Circulation, 116, 427, 10.1161/CIRCULATIONAHA.106.680421 Morrow, 2005, Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease, JAMA, 294, 2866, 10.1001/jama.294.22.2866 Post, 2008, B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients, Crit Care Med, 36, 3030, 10.1097/CCM.0b013e31818b9153 Mehra, 2004, Obesity and suppressed B-type natriuretic peptide levels in heart failure, J Am Coll Cardiol, 43, 1590, 10.1016/j.jacc.2003.10.066 Iwanaga, 2006, B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure, J Am Coll Cardiol, 47, 742, 10.1016/j.jacc.2005.11.030 Maeda, 1998, Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction, Am Heart J, 135, 825, 10.1016/S0002-8703(98)70041-9 Dokainish, 2004, Optimal non-invasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters, Circulation, 109, 2432, 10.1161/01.CIR.0000127882.58426.7A Kazanegra, 2001, A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study, J Cardiac Failure, 7, 21, 10.1054/jcaf.2001.23355 Mair, 2007, B-type natriuretic peptide (BNP) is more sensitive to rapid hemodynamic changes in acute heart failure than N-terminal proBNP, Clin Chim Acta, 379, 163, 10.1016/j.cca.2006.12.018 Paulus, 2007, How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology, Eur Heart J, 28, 2539, 10.1093/eurheartj/ehm037 Bruch, 2005, Usefulness of tissue Doppler imaging for estimation of left ventricular filling pressures in patients with systolic and diastolic heart failure, Am J Cardiol, 95, 892, 10.1016/j.amjcard.2004.12.017 Isnard, 2003, Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure, Am Heart J, 146, 729, 10.1016/S0002-8703(03)00365-X Cheng, 2001, A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study, J Am Coll Cardiol, 37, 386, 10.1016/S0735-1097(00)01157-8 Logeart, 2004, Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure, J Am Coll Cardiol, 43, 635, 10.1016/j.jacc.2003.09.044 Stevenson, 2006, Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are relevant, Circulation, 113, 1020, 10.1161/CIRCULATIONAHA.104.478321 Troughton, 2000, Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations, Lancet, 355, 1126, 10.1016/S0140-6736(00)02060-2 Jourdain, 2007, Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study, J Am Coll Cardiol, 49, 1733, 10.1016/j.jacc.2006.10.081 Pfisterer, 2009, BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial, JAMA, 301, 383, 10.1001/jama.2009.2 Binanay, 2005, Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial, JAMA, 294, 1625, 10.1001/jama.294.13.1625 Richard, 2003, Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial, JAMA, 290, 2713, 10.1001/jama.290.20.2713 Shah, 2005, Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials, JAMA, 294, 1664, 10.1001/jama.294.13.1664 Nieminen, 2005, Diagnosis and treatment of acute heart failure. Guidelines of the European Society of Cardiology, Kardiol Pol, 63, 143 Le Jemtel, 2006, Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are outdated, Circulation, 113, 1027 Gheorghiade, 2005, Acute heart failure syndromes: current state and framework for future research, Circulation, 112, 3958, 10.1161/CIRCULATIONAHA.105.590091 Hoppe, 2009, Chronic monitoring of pulmonary artery pressure in patients with severe heart failure: multicenter experience of the monitoring Pulmonary Artery Pressure by Implantable device Responding to Ultrasonic Signal (PAPIRUS) II Study, Heart, 10.1136/hrt.2008.153486